Harvard Bioscience (HBIO) Reports Q4 EPS of $0.02
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.02, versus ($0.02) reported last year. Revenue for the quarter came in at $33.1 million, versus $31 million reported last year.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
- Workhorse Group (WKHS) Misses Q2 EPS by 77c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
